Trials / Completed
CompletedNCT02286596
Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Homozygous familial hypercholesterolemia (HoFH) is characterized by a six- to eight-fold raise in plasma LDL-cholesterol (LDL-C) concentrations and atherosclerotic coronary artery disease usually occur before the age of 20 if untreated. Lipid apheresis (LA) has been proved to be a reliable method to decrease LDL-C concentrations and therefore decrease cardiovascular disease risk in HoFH. The objective of this crossover study was to compare efficacy of LA performed with heparin-induced extracorporeal LDL precipitation to dextran sulfate adsorption on the reduction of lipids, inflammatory markers, adhesion molecules and LDL particles size in a cohort of HoFH subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | heparin-induced extracorporeal LDL precipitation | Lipid apheresis for 3 hours |
| DEVICE | dextran sulfate adsorption | Lipid apheresis for 3 hours |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2013-06-01
- Completion
- 2014-12-01
- First posted
- 2014-11-10
- Last updated
- 2016-03-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02286596. Inclusion in this directory is not an endorsement.